Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS

Abroad (travel likely)RecruitingPHASE1

Conditions

ARDS (Acute Respiratory Distress Syndrome)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Virginia Commonwealth University (VCU Health), Richmond, Virginia, United States
Contact: Study coordinator (Lacey Harris, MPH, BSN) · Lacey.Harris@vcuhealth.org · 804-828-0404
Virginia Commonwealth University (VCU Health), Richmond, Virginia, United States
Contact: Study coordinator (Lacey Harris, MPH, BSN) · Lacey.Harris@vcuhealth.org · 804-828-0404

Study leads

Jianjie Ma, PhD
Study Director
HTIC, Inc

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Lung Injury is One of the Primary Causes of Morbidity and Mortality in Critically Ill Patients. These Patients Will be Monitored for: 1) Immune Cell Activation 2) Blood-based Biomarkers. In Vitro Models Derived From These Samples Will be Treated With Novel Agent PIP-2 to Evaluate Its Efficacy.

ARDS (Acute Respiratory Distress Syndrome)

Abroad (travel likely)Recruiting

Philadelphia, United States

Titration of Positive End-expiratory Pressure: Comparison Between Manual Thoracic or Abdominal Compression and Electrical Impedance Tomography

ARDS (Acute Respiratory Distress Syndrome)

Abroad (travel likely)Recruiting

Créteil, France · Lyon, France

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab

Acute Respiratory Distress Syndrome (ARDS) · ARDS · ARDS (Acute Respiratory Distress Syndrome)

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Fresno, United States

The APS Phenotyping Study

ARDS · Sepsis · Pneumonia

Abroad (travel likely)Recruiting

Fresno, United States · Palo Alto, United States